NeuroPace Inc - Common Stock, par value $0.001 per share (NPCE)

CUSIP: 641288105

Q4 2025 13F Holders as of 31 Dec 2025

Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
33,235,472
Total 13F shares
26,299,826
Share change
+706,379
Total reported value
$405,917,159
Price per share
$15.44
Number of holders
100
Value change
+$12,534,292
Number of buys
61
Number of sells
34

Quarterly Holders Quick Answers

What is CUSIP 641288105?
CUSIP 641288105 identifies NPCE - NeuroPace Inc - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of NeuroPace Inc - Common Stock, par value $0.001 per share (NPCE) as of Q4 2025

As of 31 Dec 2025, NeuroPace Inc - Common Stock, par value $0.001 per share (NPCE) was held by 100 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 26,299,826 shares. The largest 10 holders included Polar Capital Holdings Plc, Soleus Capital Management, L.P., MORGAN STANLEY, ORBIMED ADVISORS LLC, BlackRock, Inc., Driehaus Capital Management LLC, VANGUARD GROUP INC, First Light Asset Management, LLC, DEUTSCHE BANK AG\, and ARMISTICE CAPITAL, LLC. This page lists 100 institutional shareholders reporting positions in this security for the Q4 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.